Journal
APPLIED ORGANOMETALLIC CHEMISTRY
Volume 33, Issue 9, Pages -Publisher
WILEY
DOI: 10.1002/aoc.4953
Keywords
bimodal; MRI contrast agent; relaxivity; tetraphenylporphyrin
Categories
Funding
- Open Project Fund of Guangdong Provincial Key Laboratory of Emergency Test for Dangerous Chemicals [KF2017001]
- Science and Technology Planning Project of Guangdong Province [2016B020240006]
Ask authors/readers for more resources
A bimodal magnetic resonance imaging contrast agent, TPP-M-Gd, was developed by modifying tetraphenylporphyrin (TPP) with a small dendritic molecule as a ligand (M) to chelate gadolinium (Gd) ions. The ligand featured four carboxylate groups, which contributed to good water solubility and a strong combination with metal ions. The longitudinal relaxivity (R-1) of the resulting agent was calculated to be 12.45 mM(-1) s(-1), which is much higher than that of DTPA-Gd (4.49 mM(-1) s(-1)). The magnetic resonance imaging experiments showed that the newly synthesized contrast agent could enhance T-1-weighted magnetic resonance imaging quality both in vitro and in vivo. In addition, TPP-M-Gd exhibited good fluorescent property as shown in cell imaging experiments. The cytotoxicity of TPP-M-Gd was even better than that of clinically approved DTPA-Gd, which makes it a promising dual-functional medical imaging agent to provide more detailed information about biological and disease-related events.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available